Fieldpoint Private Securities, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Fieldpoint Private Securities, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2022$475,000
-17.2%
5,624
-14.0%
0.14%
+16.9%
Q1 2022$574,000
+11.2%
6,538
+10.9%
0.12%
+16.8%
Q4 2021$516,000
+13.9%
5,895
+6.5%
0.10%
+1.0%
Q3 2021$453,000
-9.0%
5,535
+2.6%
0.10%
-8.3%
Q2 2021$498,000
+13.2%
5,397
+4.8%
0.11%
+5.8%
Q1 2021$440,000
-9.5%
5,152
+0.1%
0.10%
-6.4%
Q4 2020$486,000
-37.4%
5,147
-42.3%
0.11%
-52.0%
Q3 2020$776,000
+23.4%
8,924
+23.8%
0.23%
+8.0%
Q2 2020$629,000
+75.2%
7,206
+65.8%
0.21%
+53.6%
Q1 2020$359,000
-4.5%
4,345
+9.4%
0.14%
+25.5%
Q4 2019$376,000
+26.6%
3,970
+16.1%
0.11%
+1.9%
Q3 2019$297,000
-4.8%
3,4200.0%0.11%
+10.2%
Q2 2019$312,000
+13.9%
3,420
+20.0%
0.10%
-13.3%
Q1 2019$274,000
+11.8%
2,8500.0%0.11%
+3.7%
Q4 2018$245,000
-8.2%
2,850
-8.1%
0.11%
+7.9%
Q3 2018$267,000
+7.2%
3,100
-6.1%
0.10%
+6.3%
Q2 2018$249,000
-6.7%
3,3000.0%0.10%
-22.1%
Q1 2018$267,000
-14.1%
3,300
-10.8%
0.12%
-25.6%
Q4 2017$311,000
-22.2%
3,700
-20.5%
0.16%
-5.2%
Q3 2017$400,000
+29.4%
4,657
+25.9%
0.17%
-18.0%
Q2 2017$309,000
+12.4%
3,7000.0%0.21%
-1.4%
Q1 2017$275,0003,7000.21%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders